Center for Global Development: Reflections on 15 Years of “Market Shaping”: The Case of the Pentavalent Vaccine
Rachel Silverman, a policy fellow at the Center for Global Development, discusses a paper published in the August issue of Vaccine: X, in which “former and current employees and partners of Gavi, the Vaccine Alliance reflect on their 15 years of ‘market shaping’ experience — that is, Gavi’s efforts to use its purchasing power and other tools to create more favorable market conditions — for the pentavalent vaccine (often called ‘penta’).” Silverman offers her own analysis on the broader context of procurement, concluding, “I encourage you to read the whole thing — and I urge others in the market shaping world to clearly document (and empirically evaluate!) your efforts” (9/12).